UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Local Microbiome in Esophageal Cancer and Treatment Response: A Review of Emerging Data and Future Directions

Cancers, 2023-07, Vol.15 (14), p.3562

2023

Volltextzugriff (PDF)

Effect of Neoadjuvant Chemotherapy on Tumor-Infiltrating Lymphocytes in Resectable Gastric Cancer: Analysis from a Western Academic Center

Cancers, 2024-04, Vol.16 (7), p.1428

2024

Volltextzugriff (PDF)

Fair Attribute Classification through Latent Space De-biasing

2021 IEEE/CVF Conference on Computer Vision and Pattern Recognition (CVPR), 2021, p.9297-9306

2021

Volltextzugriff (PDF)

Immunotherapy in Esophagogastric Cancer: Treatment Landscape, Challenges, and New Directions

Journal of gastrointestinal cancer, 2024-03, Vol.55 (1), p.153-167

2024

Volltextzugriff (PDF)

Which grades are better, A’s and C’s, or all B’s? Effects of variability in grades on mock college admissions decisions

Judgment and decision making, 2019-11, Vol.14 (6), p.696-710

2019

Volltextzugriff (PDF)

Immune Landscape of Epstein–Barr Virus–Associated Gastric Cancer: Analysis From a Western Academic Institution

The Journal of surgical research, 2024-04, Vol.296, p.742-750

2024

Volltextzugriff (PDF)

Information-Theoretic Segmentation by Inpainting Error Maximization

2021 IEEE/CVF Conference on Computer Vision and Pattern Recognition (CVPR), 2021, p.4028-4038

2021

Volltextzugriff (PDF)

A Randomized Phase II Trial of mFOLFOX6 + Bevacizumab Alone or with AdCEA Vaccine + Avelumab Immunotherapy for Untreated Metastatic Colorectal Cancer

The oncologist (Dayton, Ohio), 2022-03, Vol.27 (3), p.198-209

2022

Volltextzugriff (PDF)

Response to PD-1 inhibitor after progression on PD-L1 inhibitor in advanced HCC

BMJ case reports, 2022-08, Vol.15 (8), p.e250009

2022

Volltextzugriff (PDF)

A Phase II Study of Potentiation of Pembrolizumab with Binimetinib and Bevacizumab in Refractory Microsatellite-Stable Colorectal Cancer

Clinical cancer research, 2024-09, Vol.30 (17), p.3768-3778

2024

Volltextzugriff (PDF)

Overlooked Factors in Concept-Based Explanations: Dataset Choice, Concept Learnability, and Human Capability

2023 IEEE/CVF Conference on Computer Vision and Pattern Recognition (CVPR), 2023, p.10932-10941

2023

Volltextzugriff (PDF)

Association of Homologous Recombination-DNA Damage Response Gene Mutations with Immune Biomarkers in Gastroesophageal Cancers

Molecular cancer therapeutics, 2022-01, Vol.21 (1), p.227-236

2022

Volltextzugriff (PDF)

Zolbetuximab plus chemotherapy for locally advanced unresectable or metastatic stomach or gastroesophageal junction cancers: a plain language summary

Future oncology (London, England), 2024-05, p.1-17

2024

Volltextzugriff (PDF)

Chemotherapy delivery in early-onset colorectal cancer is impacted by urban versus rural settings in Colorado

Colorectal cancer, 2024-12, Vol.13 (1)

2024

Volltextzugriff (PDF)

Low molecular weight heparin versus rivaroxaban in the treatment of venous thromboembolism in gastrointestinal malignancies

Blood coagulation & fibrinolysis, 2018-03, Vol.29 (2), p.227-230

2018

Volltextzugriff (PDF)

HIVE: Evaluating the Human Interpretability of Visual Explanations

Computer Vision - ECCV 2022, 2022, Vol.13672, p.280-298

2022

Volltextzugriff (PDF)

Understanding the efficacy of frontline therapies for hepatocellular carcinoma through etiologic stratification

Journal of clinical oncology, 2024-01, Vol.42 (3_suppl), p.491-491

2024

Volltextzugriff (PDF)

Disparities and trends in biomarker testing in metastatic colorectal cancer

Journal of clinical oncology, 2024-01, Vol.42 (3_suppl), p.29-29

2024

Volltextzugriff (PDF)

Real-world analysis of irinotecan (iri) with or without fluorouracil (5FU) in the second line treatment (2L) of metastatic colorectal cancer (mCRC)

Journal of clinical oncology, 2024-01, Vol.42 (3_suppl), p.102-102

2024

Volltextzugriff (PDF)

MO31-4 Phase 1b/2 trial of tucatinib+trastuzumab+/-chemotherapy or pembrolizumab in patients with metastatic HER2+ GI cancers

Annals of oncology, 2022-07, Vol.33, p.S502

2022

Volltextzugriff (PDF)

Phase 1b/2, open-label, dose-escalation and expansion trial of tucatinib in combination with trastuzumab with and without oxaliplatin-based chemotherapy or pembrolizumab in patients with unresectable or metastatic HER2+ gastrointestinal cancers (trial in progress)

Journal of clinical oncology, 2022-02, Vol.40 (4_suppl), p.TPS376-TPS376

2022

Volltextzugriff (PDF)

Impact of early-onset colorectal cancer on utilization of chemotherapy and outcomes in patients with stage II disease

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.85-85

2023

Volltextzugriff (PDF)

Trial in progress: A phase II study (with safety run-in) of evorpacept (ALX148), cetuximab, and pembrolizumab in patients with refractory microsatellite-stable metastatic colorectal cancer (AGICC-ALX148 21CRC01)

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.TPS257-TPS257

2023

Volltextzugriff (PDF)

Tissue tumor mutational burden (TMB) as a biomarker of efficacy with immune checkpoint inhibitors (ICI) in metastatic gastrointestinal (mGI) cancers

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e14559-e14559

2021

Volltextzugriff (PDF)

1 – 25 von 90

Suche als RSS-Feed

Aktive Filter

ThemaAdult

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(76)
Mit Volltextzugriff
(73)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(90)

Erscheinungsjahr

n.n

Thema

Science & Technology
(32)
Life Sciences & Biomedicine
(21)
Humans
(16)
Oncology
(14)
Computer Science
(10)
Technology
(10)
Immunotherapy
(9)
Cancer
(8)
Social Sciences
(8)
Education & Educational Research
(6)
Gastric Cancer
(6)
Cancer Therapies
(5)
Chemotherapy
(5)
Computer Science, Artificial Intelligence
(5)
Computer Science, Interdisciplinary Applications
(5)
Esophageal Cancer
(5)
Instructional Design
(5)
Metastasis
(5)
Patients
(5)
Tumors
(5)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

The Local Microbiome in Esophageal Cancer and Treatment Response: A Review of Emerging Data and Future Directions

Effect of Neoadjuvant Chemotherapy on Tumor-Infiltrating Lymphocytes in Resectable Gastric Cancer: Analysis from a Western Academic Center

Fair Attribute Classification through Latent Space De-biasing

First-in-Human Dose-Escalation Study of the Novel Oral Depsipeptide Class I-Targeting HDAC Inhibitor Bocodepsin (OKI-179) in Patients with Advanced Solid Tumors

Immunotherapy in Esophagogastric Cancer: Treatment Landscape, Challenges, and New Directions

Which grades are better, A’s and C’s, or all B’s? Effects of variability in grades on mock college admissions decisions

Immune Landscape of Epstein–Barr Virus–Associated Gastric Cancer: Analysis From a Western Academic Institution

Information-Theoretic Segmentation by Inpainting Error Maximization

A Randomized Phase II Trial of mFOLFOX6 + Bevacizumab Alone or with AdCEA Vaccine + Avelumab Immunotherapy for Untreated Metastatic Colorectal Cancer

Response to PD-1 inhibitor after progression on PD-L1 inhibitor in advanced HCC

A Phase II Study of Potentiation of Pembrolizumab with Binimetinib and Bevacizumab in Refractory Microsatellite-Stable Colorectal Cancer

Overlooked Factors in Concept-Based Explanations: Dataset Choice, Concept Learnability, and Human Capability

Association of Homologous Recombination-DNA Damage Response Gene Mutations with Immune Biomarkers in Gastroesophageal Cancers

Zolbetuximab plus chemotherapy for locally advanced unresectable or metastatic stomach or gastroesophageal junction cancers: a plain language summary

Chemotherapy delivery in early-onset colorectal cancer is impacted by urban versus rural settings in Colorado

Low molecular weight heparin versus rivaroxaban in the treatment of venous thromboembolism in gastrointestinal malignancies

HIVE: Evaluating the Human Interpretability of Visual Explanations

Understanding the efficacy of frontline therapies for hepatocellular carcinoma through etiologic stratification

Disparities and trends in biomarker testing in metastatic colorectal cancer

Real-world analysis of irinotecan (iri) with or without fluorouracil (5FU) in the second line treatment (2L) of metastatic colorectal cancer (mCRC)

MO31-4 Phase 1b/2 trial of tucatinib+trastuzumab+/-chemotherapy or pembrolizumab in patients with metastatic HER2+ GI cancers

Phase 1b/2, open-label, dose-escalation and expansion trial of tucatinib in combination with trastuzumab with and without oxaliplatin-based chemotherapy or pembrolizumab in patients with unresectable or metastatic HER2+ gastrointestinal cancers (trial in progress)

Impact of early-onset colorectal cancer on utilization of chemotherapy and outcomes in patients with stage II disease

Trial in progress: A phase II study (with safety run-in) of evorpacept (ALX148), cetuximab, and pembrolizumab in patients with refractory microsatellite-stable metastatic colorectal cancer (AGICC-ALX148 21CRC01)

Tissue tumor mutational burden (TMB) as a biomarker of efficacy with immune checkpoint inhibitors (ICI) in metastatic gastrointestinal (mGI) cancers

Aktive Filter

Suchergebnisse filtern